Will bring up to 100 new jobs to the state
Genentech, a Roche Group company headquartered in South San Francisco, CA, US, plans to invest more than US$125m to expand its fill/finish facility in Hillsboro, Oregon, US.
Larry Sanders, General Manager and Vice President, Hillsboro Technical Operations, said the investment in the biotechnology company's sterile production operations will result in the addition of up to 100 skilled manufacturing jobs in the greater Portland area over the next five years, potentially bringing the total number of Genentech jobs in Oregon to more than 500.
Genentech started operations in Hillsboro in April 2010. As well as the fill/finish facility, the site also includes a warehousing and distribution centre. Increasing manufacturing capacity will help the company meet growing demand for its products.